Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%), etc.
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.3%),Point72 Capital Advisors, Inc.(3.3%), etc.
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(4.7%),Avidity Partners Management (GP) LLC(4.7%), etc.
Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.11%)
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Metzger Michael A
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goldan Keith A.
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gallagher Neil
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Legault Pierre
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Podlesak Dennis
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Meury William
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Katkin Keith
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jarrett Jennifer
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Huber Martin H. Jr.
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(8.94%),Wellington Group Holdings LLP(8.94%), etc.
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.3%)
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(5.91%)
Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Steven A. Cohen(5.1%),Point72 Asset Management, L.P.(4.5%), etc.
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Frazier Life Sciences Public Fund, L.P.(0.0%),FHMLSP, L.P.(0.0%), etc.
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
No Data